CH417576A - Process for the preparation of 1,2a-methylene-6-17a-hydroxy-progesterone esters halogenated in the 6-position - Google Patents

Process for the preparation of 1,2a-methylene-6-17a-hydroxy-progesterone esters halogenated in the 6-position

Info

Publication number
CH417576A
CH417576A CH214862A CH214862A CH417576A CH 417576 A CH417576 A CH 417576A CH 214862 A CH214862 A CH 214862A CH 214862 A CH214862 A CH 214862A CH 417576 A CH417576 A CH 417576A
Authority
CH
Switzerland
Prior art keywords
methylene
hydroxy
preparation
progesterone esters
halogenated
Prior art date
Application number
CH214862A
Other languages
German (de)
Inventor
Rudolf Dr Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH417576A publication Critical patent/CH417576A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH214862A 1961-04-29 1962-02-22 Process for the preparation of 1,2a-methylene-6-17a-hydroxy-progesterone esters halogenated in the 6-position CH417576A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESCH29643A DE1158966B (en) 1961-04-29 1961-04-29 Process for the preparation of 6-chloro-1,2ª‡-methylene-í¸-17ª‡-hydroxyprogesterone esters

Publications (1)

Publication Number Publication Date
CH417576A true CH417576A (en) 1966-07-31

Family

ID=7431494

Family Applications (1)

Application Number Title Priority Date Filing Date
CH214862A CH417576A (en) 1961-04-29 1962-02-22 Process for the preparation of 1,2a-methylene-6-17a-hydroxy-progesterone esters halogenated in the 6-position

Country Status (6)

Country Link
US (1) US3234093A (en)
BE (1) BE616989A (en)
BR (1) BR6238435D0 (en)
CH (1) CH417576A (en)
DE (1) DE1158966B (en)
GB (1) GB973908A (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1050218A (en) * 1964-10-13
US3401163A (en) * 1965-10-21 1968-09-10 Squibb & Sons Inc Preparation of methylene steroids
US3423507A (en) * 1966-02-25 1969-01-21 Schering Corp Method of treating benign prostratic hypertrophy
DE2345377A1 (en) * 1973-09-06 1975-03-20 Schering Ag PHARMACEUTICAL PREPARATION I
GB1570524A (en) * 1976-03-11 1980-07-02 Unilever Ltd Cosmetic
DE2712861C2 (en) * 1977-03-21 1986-02-27 Schering AG, 1000 Berlin und 4709 Bergkamen 17-acetoxy-6-chloro-15β-hydroxy-1α, 2α-methylene-4,6-pregnadiene-3,20-dione, process for its preparation and medicament containing it
DE3331824A1 (en) * 1983-09-01 1985-03-21 Schering AG, Berlin und Bergkamen, 1000 Berlin METHOD FOR PRODUCING 17 (ALPHA) -ACYLOXY-6-CHLORINE-1 (ALPHA), 2 (ALPHA) -METHYLENE-3,20-DIONES
US5439901A (en) * 1993-07-23 1995-08-08 The Procter & Gamble Company Cyproterone thiopivalate
US5468104A (en) 1994-08-10 1995-11-21 Fatigue Technology, Inc. Wall nut assembly
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
US20040024230A1 (en) * 2002-04-29 2004-02-05 Boehringer Ingelheim International Gmbh Synthesis of cyproterone acetate
EP1359154A1 (en) * 2002-04-29 2003-11-05 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Further syntheses of cyproterone acetate
EP2428516A1 (en) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
DK2278880T3 (en) 2008-04-09 2012-11-12 Pherin Pharm Inc Steroid treatment of hot flashes
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
AU2013353723B2 (en) 2012-12-03 2018-02-22 Pfizer Inc. Novel selective androgen receptor modulators

Also Published As

Publication number Publication date
GB973908A (en) 1964-11-04
BR6238435D0 (en) 1973-05-24
DE1158966B (en) 1963-12-12
US3234093A (en) 1966-02-08
BE616989A (en) 1962-10-29

Similar Documents

Publication Publication Date Title
CH412918A (en) Process for the preparation of 1,8-naphthyridines
CH417576A (en) Process for the preparation of 1,2a-methylene-6-17a-hydroxy-progesterone esters halogenated in the 6-position
CH420067A (en) Process for the preparation of ortho-alkylphenols
CH457473A (en) Process for the preparation of 9,10-dihydroergovaline
CH376898A (en) Process for the preparation of 2,3-dimethoxy-5-methyl-benzohydroquinones- (1,4) or benzoquinones- (1,4) substituted in the 6-position
CH425813A (en) Process for the preparation of trialkalinitrilotriacetate
AT255031B (en) Process for the preparation of 1-glycosyl-6-azauracils
CH419146A (en) Process for the preparation of 3-phenyl-7-pyrazolyl-coumarins
CH420186A (en) Process for the preparation of 2-amino-benzophenones
CH420185A (en) Process for the preparation of 5-mononucleotides
AT239438B (en) Process for the preparation of α-aminobenzylpenicillin
AT241687B (en) Process for the preparation of α-aminobenzylpenicillin
CH410901A (en) Process for the preparation of 2-halo and 2,4-dihalo-alkylphenyl carbamates
CH420135A (en) Process for the preparation of 16-alkylpregnenes
CH413836A (en) Process for the preparation of distilbazoles
CH420168A (en) Process for the preparation of sulfapyrimidines
CH397715A (en) Process for the preparation of 2,5-diarylaminoterephthalic acids
CH404652A (en) Process for the preparation of 1,4-3-keto steroids
CH401026A (en) Process for the preparation of B-ketoamides
CH427793A (en) Process for the preparation of benzenesulfonylsemicarbazides
CH432487A (en) Process for the preparation of mononitro-1,3,5-trialkylbenzene
CH415675A (en) Process for the preparation of 4-methyl-6-isobutenyl-pyrone- (2)
CH407086A (en) Process for the preparation of 1,2,3,4-tetraalkyl-anthraquinone-8-carboxylic acids
CH422788A (en) Process for the preparation of 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-quinolines
CH401949A (en) Process for the preparation of 1-alkyl-1-alkoxy-3-arylurea